» Articles » PMID: 25347746

Chromosomal Instability Causes Sensitivity to Metabolic Stress

Overview
Journal Oncogene
Date 2014 Oct 28
PMID 25347746
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Chromosomal INstability (CIN), a hallmark of cancer, refers to cells with an increased rate of gain or loss of whole chromosomes or chromosome parts. CIN is linked to the progression of tumors with poor clinical outcomes such as drug resistance. CIN can give tumors the diversity to resist therapy, but it comes at the cost of significant stress to tumor cells. To tolerate this, cancer cells must modify their energy use to provide adaptation against genetic changes as well as to promote their survival and growth. In this study, we have demonstrated that CIN induction causes sensitivity to metabolic stress. We show that mild metabolic disruption that does not affect normal cells, can lead to high levels of oxidative stress and subsequent cell death in CIN cells because they are already managing elevated stress levels. Altered metabolism is a differential characteristic of cancer cells, so our identification of key regulators that can exploit these changes to cause cell death may provide cancer-specific potential drug targets, especially for advanced cancers that exhibit CIN.

Citing Articles

Genome-wide identification and functional validation of the WW domain containing oxidoreductase gene associated with sleep duration.

Kim S, Kang S, Kim S, Kim H, Kim S, Lee Y Sci Rep. 2025; 15(1):5552.

PMID: 39952983 PMC: 11828923. DOI: 10.1038/s41598-024-81158-8.


Targeting chromosomal instability in patients with cancer.

Al-Rawi D, Lettera E, Li J, DiBona M, Bakhoum S Nat Rev Clin Oncol. 2024; 21(9):645-659.

PMID: 38992122 DOI: 10.1038/s41571-024-00923-w.


Aneuploidy is Linked to Neurological Phenotypes Through Oxidative Stress.

Islam A, Shaukat Z, Hussain R, Ricos M, Dibbens L, Gregory S J Mol Neurosci. 2024; 74(2):50.

PMID: 38693434 PMC: 11062972. DOI: 10.1007/s12031-024-02227-1.


Chromosomal Instability-Driven Cancer Progression: Interplay with the Tumour Microenvironment and Therapeutic Strategies.

Zheng S, Guerrero-Haughton E, Foijer F Cells. 2023; 12(23).

PMID: 38067140 PMC: 10706135. DOI: 10.3390/cells12232712.


The fate of extra centrosomes in newly formed tetraploid cells: should I stay, or should I go?.

Bloomfield M, Cimini D Front Cell Dev Biol. 2023; 11:1210983.

PMID: 37576603 PMC: 10413984. DOI: 10.3389/fcell.2023.1210983.


References
1.
Carter S, Eklund A, Kohane I, Harris L, Szallasi Z . A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet. 2006; 38(9):1043-8. DOI: 10.1038/ng1861. View

2.
Zhang C, Zhang Z, Zhu Y, Qin S . Glucose-6-phosphate dehydrogenase: a biomarker and potential therapeutic target for cancer. Anticancer Agents Med Chem. 2013; 14(2):280-9. DOI: 10.2174/18715206113136660337. View

3.
Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

4.
Baker D, Jin F, Jeganathan K, van Deursen J . Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell. 2009; 16(6):475-86. PMC: 2842992. DOI: 10.1016/j.ccr.2009.10.023. View

5.
Weaver B, Cleveland D . Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res. 2007; 67(21):10103-5. PMC: 3132555. DOI: 10.1158/0008-5472.CAN-07-2266. View